Deutsche Bank’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-21,139
| Closed | -$398K | – | 4992 |
|
|
2019
Q3 | $398K | Sell |
21,139
-2,923
| -12% | -$55K | ﹤0.01% | 2770 |
|
|
2019
Q2 | $281K | Buy |
24,062
+4,586
| +24% | +$53.6K | ﹤0.01% | 3582 |
|
|
2019
Q1 | $265K | Sell |
19,476
-250,033
| -93% | -$3.4M | ﹤0.01% | 3761 |
|
|
2018
Q4 | $2.76M | Sell |
269,509
-73,492
| -21% | -$753K | ﹤0.01% | 2186 |
|
|
2018
Q3 | $5.71M | Sell |
343,001
-65,755
| -16% | -$1.09M | ﹤0.01% | 2074 |
|
|
2018
Q2 | $6.46M | Sell |
408,756
-112,552
| -22% | -$1.78M | ﹤0.01% | 2096 |
|
|
2018
Q1 | $6.62M | Buy |
521,308
+216,336
| +71% | +$2.75M | ﹤0.01% | 1971 |
|
|
2017
Q4 | $3.49M | Buy |
304,972
+61,611
| +25% | +$705K | ﹤0.01% | 2307 |
|
|
2017
Q3 | $2.98M | Buy |
243,361
+76,778
| +46% | +$940K | ﹤0.01% | 2243 |
|
|
2017
Q2 | $1.91M | Buy |
166,583
+44,813
| +37% | +$512K | ﹤0.01% | 2568 |
|
|
2017
Q1 | $2.53M | Sell |
121,770
-36,760
| -23% | -$764K | ﹤0.01% | 2089 |
|
|
2016
Q4 | $3.29M | Sell |
158,530
-25,295
| -14% | -$526K | ﹤0.01% | 1925 |
|
|
2016
Q3 | $6.02M | Buy |
183,825
+5,112
| +3% | +$167K | ﹤0.01% | 1614 |
|
|
2016
Q2 | $4.46M | Sell |
178,713
-130,452
| -42% | -$3.26M | ﹤0.01% | 1839 |
|
|
2016
Q1 | $7.57M | Buy |
309,165
+267,659
| +645% | +$6.55M | 0.01% | 1454 |
|
|
2015
Q4 | $1.37M | Sell |
41,506
-27,949
| -40% | -$922K | ﹤0.01% | 2648 |
|
|
2015
Q3 | $2.27M | Sell |
69,455
-19,498
| -22% | -$638K | ﹤0.01% | 2384 |
|
|
2015
Q2 | $4.71M | Buy |
88,953
+70,516
| +382% | +$3.73M | ﹤0.01% | 1829 |
|
|
2015
Q1 | $530K | Buy |
18,437
+18,403
| +54,126% | +$529K | ﹤0.01% | 3190 |
|
|
2014
Q4 | $0 | Sell |
34
-10,210
| -100% | – | ﹤0.01% | 5637 |
|
|
2014
Q3 | $128K | Buy |
10,244
+2,164
| +27% | +$27K | ﹤0.01% | 4089 |
|
|
2014
Q2 | $161K | Buy |
+8,080
| New | +$161K | ﹤0.01% | 4072 |
|